Clinical Trial

A Novel Fluorescent Ductal Needle for Localization and Sampling of High-risk Breast Micro Lesions

Recruiting
View on ClinicalTrials.gov →
Summary
This retrospective cohort study investigates the differences in the reliability of rapid pathology compared to postoperative pathology when utilizing a novel fluorescent localization needle equipped with a controllable shedding quantum dot chiral nanofluorescent coating, in contrast to traditional localization techniques for breast duct lesions. The primary goal is to evaluate the clinical effectiveness of this innovative fluorescent localization needle in facilitating accurate pathological diagnoses of micro lesions situated within breast ducts.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-05-20; most recent amendment 2026-06-10.
Status change: Not Yet Recruiting → Recruiting 2026-01-14
Trial Details
NCT Number NCT06994416
Lead Sponsor The Fourth Affiliated Hospital of China Medical University
Conditions Mammary Tumor, Nipple Discharge
Enrollment 300 participants
Start Date 2025-06-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-11